Mammography Decision Support for Breast Cancer Screening

Testing a Mammography Decision Intervention in a Rural Setting

Recruiting N/A Interventional Study
Breast Cancer
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
39 – 49
Sex
Female
Study type
Interventional
Purpose
Prevention
Participants needed
39 (estimated)
Sponsor
Dartmouth-Hitchcock Medical Center · Other
Who this trial is looking for

This trial is looking for women aged 39-49 who have an appointment with a primary care provider. Participants will help test a new decision support tool for breast cancer screening in rural areas.

Are You a Good Fit for This Trial?

You may be able to join if

  • I am female
  • I am aged 39-49
  • I have an upcoming appointment with a participating primary care provider
  • I speak English or Spanish

You may not be able to join if

  • I have a personal history of breast cancer
  • I had a mammogram in the prior 12 months

Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.

Think this trial could be right for you?

Answer three quick questions written from this study's own rules to see if you may qualify. No account needed to find out.

Check Your Eligibility
About This Trial
The overall objective of this COBRE pilot project is to enhance the design of a 3-arm cluster randomized trial that will test the efficacy and mechanism of effect of the MyMammogram DA with or without a provider communication intervention. This will be accomplished through two aims: (1) Refine, with community partner input, a clinical trial protocol to optimize engagement among patients and primar…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Patient Inclusion Criteria: * Females * Aged 39-49 * Upcoming appointment with a participating primary care provider (within 4 weeks) * English or Spanish-speaking Patient Exclusion Criteria: * Personal history of breast cancer (including lobular carcinoma in situ and ductal carcinoma in situ or …
Contacts

Christine M Gunn, PhD

603-646-5430

Christine.M.Gunn@dartmouth.edu

CONTACT